Long-lasting opioid treatment recommended by an EMA committee
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
List view / Grid view
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
This issue questions whether companies are sufficiently investing in regulatory intelligence software and what the potential consequences of Brexit might be for locations outside of the UK and EU. The issue also features articles on microbiology, formulation and biopharma, courtesy of our in-depth focus sections; as well as outlining the…
The Government of Malawi has launched the world’s first malaria vaccine which will be made available to children up to two years of age.
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
The Association of the British Pharmaceutical Industry has called for a temporary ban on drugs exports in the event of a no-deal Brexit to prevent the NHS being hit by shortages...
A study has revealed an in vitro method that could screen various compounds, identifying ones that would make swallowing medicine easier...
This study will evaluate the ready-to-use, room-temperature stable liquid glucagon as a pre-treatment to prevent exercise-induced hypoglycemia...
Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration...
An absorbable antibiotic envelope could cut the number of cardiac infections after surgery to implant or replace cardioverter defibrillators and pacemakers...
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
Researchers are integrating ultrasound imaging with ultrasound therapy to pave the way for a new kind of drug delivery...
Researchers have developed a highly sensitive, mechanical needle that targets tissue reliably and precisely for the delivery of therapeutics...
Gore, a global materials science company, attends Pharmapack Europe to continue their year-long launch of the GORE™ ImproJect™ Plunger for pre-filled syringes...